FDA declines to approve Eli Lilly's bowel disease drug GastroTwitter TwitteRx
-Eli Lilly and Co said on Thursday that the U.S. Food and Drug Administration had declined to approve its drug to treat a type of chronic inflammatory bowel disease in adults.
The health regulator cited issues related to the proposed manufacturing of the drug, mirikizumab, although it did not express concerns about the clinical data package, safety, or label for the medicine, Lilly said. "The setback is fairly minor from the context of what a great portfolio Eli Lilly has and even within the drug itself, it sounds like it's manufacturing issues, so I don't think that's going to be overly problematic," Morningstar analyst Damien Conover told Reuters.
"There is still possibility this product can exceed $2 billion peak sales," Wells Fargo analyst Mohit Bansal said in a note.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US FDA declines to approve Eli Lilly's bowel disease drugEli Lilly and Co said on Thursday that the U.S. Food and Drug Administration (FDA) had declined to approve its drug to treat a type of chronic inflammatory bowel disease in adults.
Read more »
Eli Gold plans to return for Alabama’s 2023 season after spending six months in hospitals“Lord willing, and the creek don’t rise, I am planning to be back in time for the start of the regular season,” Eli Gold said. The longtime Tide radio play-by-play announcer detailed his health struggles and recovery in an interview on Mobile's WNSP.
Read more »
Carlsbad declines Oceanside's invite to join sand projectBuilding sand retention structures could increase erosion on downcoast cities, Carlsbad council members say
Read more »
US: Annual PPI declines to 2.7% in March vs. 3% expectedThe Producer Price Index (PPI) for final demand in the US declined to 2.7% on a yearly basis in March from 4.6% in February, the data published by the
Read more »
No shield for Trump in rape accuser's case as court declines to ruleA Washington, D.C., appeals court declined to shield Donald Trump from the first of two civil defamation lawsuits by E. Jean Carroll, a writer who said the former US president raped her nearly three decades ago
Read more »
No shield for Trump in rape accuser's case as court declines to ruleA Washington, D.C., appeals court on Thursday declined to shield Donald Trump from the first of two civil defamation lawsuits by E. Jean Carroll.
Read more »